SOLICITATION DOCUMENT Clause Samples

The SOLICITATION DOCUMENT clause defines the official set of documents issued by a party, typically a buyer or contracting authority, to invite bids or proposals from potential suppliers or contractors. This clause outlines what constitutes the solicitation package, which may include instructions to bidders, specifications, evaluation criteria, and contract terms. By clearly identifying the documents that form the basis of the solicitation, this clause ensures all parties are aware of the requirements and procedures, thereby promoting transparency and consistency in the procurement process.
SOLICITATION DOCUMENT. Exempt – Governmental Entity SECTION IV.
View SourceView Similar (2)
SOLICITATION DOCUMENT. Exempt - Governmental Entity N. All invoices will reference the Purchase Order Number. A. TREATMENT CONSIDERATIONS The medical literature supports the use of opioid substitution therapy as first-line treatment for patients with opioid use disorders. Substance Abuse and Mental Health Services Administration (SAMHSA), American Society of Addiction Medicine (ASAM) and the Veterans Administration (VA) indicate that extended-release injectable naltrexone may be an acceptable alternative to opioid substitution therapy in selected patients. Careful patient selection is essential in order to maximize the chance of long-term treatment success and to minimize the risk of adverse outcomes including relapse and overdose. Several organizations, including SAMHSAi, VAii, ASAMiii and Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT)iv have published guidance on which patients may be the best candidates for treatment with extended-release injectable naltrexone. Patient selection criteria based on that guidance and on a review of the other available literature are included below. These criteria are intended as guidelines and should not be considered a substitute for the clinical judgment of the treating physician. The optimal duration of treatment with extended-release injectable naltrexone has not been determined. Most studies have been based on 6 months of medication, but data on long-term outcomes is lacking. The decision to discontinue medication must be determined on a case-by- case basis and in conjunction with patient preference, taking into account the relative risks and benefits. As with other forms of medication-assisted treatment (MAT), extended-release injectable naltrexone must only be used as part of a comprehensive program of treatment that includes counseling and behavioral therapy. Patients should be encouraged to participate in recovery- related activities in addition to formal counseling. B. PHYSICIAN EDUCATION REQUIREMENTS Prior to initiation of treatment with extended-release injectable naltrexone, the ordering physician must gain a thorough understanding of the use of this medication in the treatment of patients with opioid use disorder. The treating physician must: 1. Become familiar with the published guidelines for the use of this medication, such as those by ▇▇▇▇▇▇, ASAM and the VA; 2. Become familiar with and follow the Food & Drug Administration (FDA) prescribing information, REMS and manufacturer’s recommendations r...
View Source
SOLICITATION DOCUMENT. Proprietary/Sole Source purchase.
View Source
SOLICITATION DOCUMENT. Exempt - Governmental Entity J. All invoices will reference the Purchase Order Number. A. Funding from The United States Health and Humans Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) fund the HHSC Substance Use Disorder project(s), which includes this contract. B. This contract is funded with the Catalog of Federal Domestic Assistance (CFDA) funds, Texas Targeted Opioid Response (TTOR) State Targeted Response (STR) and State Opioid Response (SOR) grants, CFDA 93.788 C. The total reimbursements for the contract are as follows: 1. In Fiscal Year 2020, the total reimbursements will not exceed $4,515,660.00, for the term September 1, 2019 through September 29, 2020. The funding is allocated as follows: a. TTOR STR grant allocation is $3,010,440.00, for the term September 1, 2019 through April 30, 2020: b. TTOR SOR grant allocation is $1,505,220.00, for the term May 1, 2020 through August 31, 2020. 2. In Fiscal Year 2021, the total reimbursements will not exceed $376,305.00, for the term September 1, 2020 through September 29, 2020. The funding is allocated from the TTOR SOR grant funds. a. TTOR SOR grant allocation is $326,502.00, for the term September 1, 2020 through September 29, 2020. D. Performing Agency Share (Match) TTOR grant funds do not require match. E. Performing Agency will submit invoices to the System Agency through the Clinical Management for Behavioral Health Services (CMBHS) system monthly. F. Any unexpended balance associated with any other System Agency Contract may not be applied to this System Agency Contract. G. System Agency funded capacity is defined as the stated number of clients that will be concurrently served as determined by this Contract. H. Clinic Numbers must be approved by the Assigned Contract Manager before billing can occur. Clinic Change Request form is located at: ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇▇▇.▇▇▇/sa/For- I. Service Types with no associated Amount will be paid from the preceding Service Type with an associated Amount.
View Source
SOLICITATION DOCUMENT. The Department of State Health Services (DSHS) Substance Abuse Intervention Programs Request for Proposals issued on November 5, 2012, RFP# SA/INTV-540.1. None
View Source
SOLICITATION DOCUMENT. A document developed by the County to obtain bids, proposals, and other information from bidders/proposers.
View Source

Related to SOLICITATION DOCUMENT

  • Formation Documents With respect to the Issuing Entity, the Certificate of Trust and the Trust Agreement, (ii) with respect to the Grantor Trust, the Grantor Trust Certificate of Trust and the Grantor Trust Agreement, and (iii) with respect to the Depositor, the certificate of formation of the Depositor filed in Delaware, dated as of January 4, 2019 and the amended and restated limited liability company agreement of the Depositor, dated as of March 27, 2019, made by the Sponsor, as member.

  • Authorization Documents For each Loan Party, such Person’s (a) charter (or similar formation document), certified by the appropriate governmental authority; (b) good standing certificates in its state of incorporation (or formation) and in each other state requested by the Administrative Agent; (c) bylaws (or similar governing document); (d) resolutions of its board of directors (or similar governing body) approving and authorizing such Person’s execution, delivery and performance of the Loan Documents to which it is party and the transactions contemplated thereby; and (e) signature and incumbency certificates of its officers executing any of the Loan Documents (it being understood that the Administrative Agent and each Lender may conclusively rely on each such certificate until formally advised by a like certificate of any changes therein), all certified by its secretary or an assistant secretary (or similar officer) as being in full force and effect without modification.

  • Organization Documents After giving effect to the transactions contemplated hereby, the Administrative Agent shall have received: (i) a copy of the Organization Documents, including all amendments thereto, of each Loan Party, certified as of a recent date by the Secretary of State or other applicable Governmental Authority of its respective jurisdiction of organization to the extent applicable; (ii) a certificate as to the good standing (or comparable status) of each Loan Party from such Secretary of State or other applicable Governmental Authority of its respective jurisdiction of organization, as of a recent date; provided that to the extent a certificate of good standing (or comparable status) is not applicable in the jurisdiction of any Loan Party that is a Foreign Subsidiary, such Loan Party shall provide an Officer’s Certificate in form and substance reasonably satisfactory to the Administrative Agent; (iii) a certificate of the Secretary or Assistant Secretary or other applicable Responsible Officer of each Loan Party dated the Closing Date and certifying (A) that the Organization Documents of such Loan Party have not been amended since the date of the last amendment thereto shown on the certificate of good standing or comparable status from its jurisdiction of organization furnished pursuant to clause (ii) above (to the extent applicable in the relevant Loan Party’s jurisdiction) and remains in full force and effect; (B) that attached thereto is a true and complete copy of the Organization Documents as in effect on the Closing Date and at all times since the date of the resolutions described in clause (C) below or certifying that such Organization Documents have not been amended since such date, (C) that attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors (or equivalent governing body) of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which it is to be a party and, in the case of the Borrowers, the borrowings hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect and are the only resolutions authorizing the execution, delivery and performance of the Loan Documents; and (D) as to the incumbency and specimen signature of each Responsible Officer executing any Loan Document; and (iv) a certificate of another officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary or other applicable Responsible Officer executing the certificate pursuant to clause (iii) above.

  • Other Transaction Documents Each representation and warranty made by the Servicer under each other Transaction Document to which it is a party (including, without limitation, the Purchase and Sale Agreement) is true and correct in all material respects as of the date when made.

  • Reference Information Documents 1.7.1 TxDOT has provided and disclosed the Reference Information Documents to DB Contractor. Except as provided in Section 1.2.3: (a) the Reference Information Documents are not mandatory or binding on DB Contractor, and (b) DB Contractor is not entitled to rely on the Reference Information Documents as presenting a design, engineering, operating or maintenance solutions or other direction, means or methods for complying with the requirements of the Contract Documents, Governmental Approvals or Law. 1.7.2 TxDOT shall not be responsible or liable in any respect for any causes of action, claims or Losses whatsoever suffered by any DB Contractor-Related Entity by reason of any use of information contained in, or any action or forbearance in reliance on, the Reference Information Documents, except any schedule or monetary relief available hereunder as set forth in Section 13 of this Agreement. 1.7.3 Except as provided in Section 1.2.3, TxDOT does not represent or warrant that the information contained in the Reference Information Documents is complete or accurate or that such information is in conformity with the requirements of the Contract Documents, Governmental Approvals or Laws. DB Contractor shall have no right to additional compensation or time extension based on any incompleteness or inaccuracy in the Reference Information Documents.